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Prevalence of Actinic Keratosis and Its Risk Factors in
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Sophie C. Flohil1, Robert J.T. van der Leest1, Emmilia A. Dowlatshahi1, Albert Hofman2,
Esther de Vries1,3 and Tamar Nijsten1
Limited data are available on the prevalence and risk factors of actinic keratoses (AKs). Within the Rotterdam
Study, full-body skin examinations were performed among participants aged 45 years or older to estimate the
age- and sex-standardized prevalence of AK and its associated risk factors. Odds ratios (ORs) with 95%
confidence intervals (CIs) were calculated for associations between risk factors and the presence of 1–3, 4–9,
andX10 AKs. Of the 2,061 inspected cohort members (mean age 72 years), 21% had 1–3, 9% had 4–9, and 8% had
X10 AKs. AK prevalence was 49% (95% CI: 46–52%) for men and 28% (26–31%) for women. Male gender, older
age, light pigmentation status, severe baldness, skin wrinkling, and high tendency for sunburn were significantly
associated with extensive actinic damage (X10 AKs) in the multivariate analyses. Especially bald males were at an
increased risk of severe actinic skin damage (adjusted OR¼ 7.0 (3.8–13.1)). The prevalence of AK is very high,
especially among elderly bald males. The prevention and management of AK is a true challenge for patients,
physicians, and health-care policymakers.
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INTRODUCTION
Actinic keratoses (AKs) are a common keratinocytic intra-
epidermal neoplasia often occurring on chronically sun-
exposed skin of Caucasian individuals (LeBoit et al., 2006).
AKs may progress to invasive cutaneous squamous cell
carcinoma (SCC) in B0.1–20% of the lesions annually
(Callen et al., 1997; Marks et al., 1988b; Quaedvlieg et al.,
2006). AKs are often diagnosed clinically (i.e., rough red scaly
patches on chronically sun-exposed skin) without histological
confirmation, and are therefore not recorded in pathology
databases and cancer registries.
Population-based studies investigating AK prevalence and
its associated risk factors (Green et al., 1988; Harvey et al.,
1996a; He et al., 2011; Marks et al., 1986; Naldi et al., 2006)
conclude that elderly subjects with European ancestry and
high cumulative UV exposure have the highest risk of
developing AKs. However, these studies are few and report
prevalences of AK varying from 1.4 to 59.2%. These
differences in prevalences could be due to the geographic
variability in UV radiation levels (Australia 4United States of
America 4Europe) and the differences between the studied
populations (e.g., high-risk patients, pigmentation status and
age restrictions). Moreover, skin examinations and AK count
were not conducted uniformly in these studies (Green et al.,
1988; Harvey et al., 1996a, b; He et al., 2011; Marks et al.,
1986; Naldi et al., 2006).
Most national guidelines or consensus reports recommend
the treatment of AK, for which a variety of modalities are
available, and follow-up of these patients because of their
invasive potential. Implementing these recommendations puts
a further burden on general physicians and the dermatological
care, which is already strained by the care of cutaneous
malignancies (Holterhues et al., 2010; Hollestein et al., 2012).
For the first time in the Netherlands, the prevalence of AK
and its associated risk factors were investigated in a popula-
tion-based cohort study (i.e., Rotterdam Study (RS)) among
2,061 elderly participants.
RESULTS
A total of 2,061 (99.9%) of 2,063 participants visiting
the RS research facility between August 2010 and April
2012 agreed to undergo a full-body skin examination (FBSE).
Hereof, 208 participants (10.1%) were from Rotterdam Study I
(RS-I), 1,542 (74.8%) were from RS-II, and 311 (15.1%) were
from RS-III. The majority of the participants were women
(55.0%; Table 1). Mean age at the date of FBSE was 71.6 years
(SD 7.1; ranging from 51 to 98 years).
Prevalence of AKs
Of 2,061 participants, 773 (37.5%) had at least one or more
AK, of which 56.0% had 1–3 AK, followed by 4–9 (22.9%)
ORIGINAL ARTICLE
1Department of Dermatology, Erasmus MC University Medical Center,
Rotterdam, The Netherlands; 2Department of Epidemiology, Erasmus MC
University Medical Center, Rotterdam, The Netherlands and 3Department of
Public Health, Erasmus MC University Medical Center, Rotterdam,
The Netherlands
Correspondence: Tamar Nijsten, Department of Dermatology, Erasmus
University Medical Center, PO Box 2040, 3000 Rotterdam, The Netherlands.
E-mail: t.nijsten@erasmusmc.nl
Received 18 November 2012; revised 19 February 2013; accepted 27
February 2013; accepted article preview online 19 March 2013; published
online 9 May 2013
Abbreviations: AK, actinic keratosis; BCC, basal cell carcinoma; CI, confidence
interval; FBSE, full-body skin examination; OR, odds ratio; RS, Rotterdam
Study; SCC, squamous cell carcinoma
& 2013 The Society for Investigative Dermatology www.jidonline.org 1971
Table 1. Study characteristics of 2,061 participants of the RS with a full-body skin examination
Total study population No AK (%) 1–3 AKs (%) 4–9 AKs (%) X10 AKs (%)
Characteristic (n¼ 2,061) (n¼ 1,288) (n¼433) (n¼ 177) (n¼163)
Sex
Women 1,134 (55.0) 815 (63.3) 220 (50.8) 58 (32.8) 41 (25.2)
Men 927 (45.0) 473 (36.7) 213 (49.2) 119 (67.2) 122 (74.8)
Age at FBSE
Mean age in years (SD) 71.6 (7.1) 70.2 (7.2) 73.0 (6.4) 74.1 (6.5) 75.6 (6.2)
o70 874 (42.4) 638 (49.5) 156 (36.0) 50 (28.2) 30 (18.4)
70–79.99 947 (45.9) 532 (41.3) 219 (50.6) 98 (55.4) 98 (60.1)
X80 240 (11.6) 118 (9.2) 58 (13.4) 29 (16.4) 35 (21.5)
Pigmentation status (based on eye, hair, and skin color)
Dark 212 (10.3) 164 (12.7) 26 (6.0) 12 (6.8) 10 (6.1)
Medium 1,294 (62.8) 813 (63.1) 272 (62.8) 116 (65.5) 93 (57.1)
Light 385 (18.7) 201 (15.6) 92 (21.2) 39 (22.0) 53 (32.5)
Data missing 170 (8.2) 110 (8.5) 43 (9.9) 10 (5.6) 7 (4.3)
Glogau scale
1 and 2 180 (8.7) 156 (12.1) 17 (3.9) 5 (2.8) 2 (1.2)
3 1,684 (81.7) 1,026 (79.7) 359 (82.9) 154 (87.0) 145 (89.0)
4 197 (9.6) 106 (8.2) 57 (13.2) 18 (10.2) 16 (9.8)
Nevi
o25 1,569 (76.1) 985 (76.5) 323 (74.6) 130 (73.4) 131 (80.4)
25–50 385 (18.7) 236 (18.3) 90 (20.8) 35 (19.8) 24 (14.7)
50 or more 107 (5.2) 67 (5.2) 20 (4.6) 12 (6.8) 8 (4.9)
Baldness1
No/almost no baldness 1,355 (65.7) 940 (73.0) 60 (13.9) 66 (37.3) 83 (50.9)
Mild baldness 389 (18.9) 240 (18.6) 86 (19.9) 35 (19.8) 28 (17.2)
Severe baldness 317 (15.4) 108 (8.4) 287 (66.3) 76 (42.9) 52 (31.9)
Tendency to develop sunburn
Low 1,330 (64.5) 873 (67.8) 275 (63.5) 108 (61.0) 74 (45.4)
High 607 (29.5) 330 (25.6) 129 (29.8) 64 (36.2) 84 (51.5)
Data missing 124 (6.0) 85 (6.6) 29 (6.7) 5 (2.8) 5 (3.1)
Outdoor work history X25 years
No 334 (16.2) 220 (17.1) 51 (11.8) 21 (11.9) 42 (25.8)
Yes 151 (7.3) 105 (8.2) 21 (4.8) 14 (7.9) 11 (6.7)
Data missing 1,576 (76.5) 963 (74.8) 361 (83.4) 142 (80.2) 110 (67.5)
History of living in sunny country of 41 year
No 1,730 (83.9) 1,064 (82.6) 367 (84.8) 163 (92.1) 136 (83.4)
Yes 213 (10.3) 145 (11.3) 37 (8.5) 9 (5.1) 22 (13.5)
Data missing 118 (5.7) 79 (6.1) 29 (6.7) 5 (2.8) 5 (3.1)
Sun-protective behavior2
Never/almost never 672 (32.6) 454 (35.2) 135 (31.2) 49 (27.7) 34 (20.9)
Often/not always 640 (31.1) 358 (27.8) 136 (31.4) 75 (42.4) 71 (43.6)
Always 631 (30.6) 397 (30.8) 133 (30.7) 48 (27.1) 53 (32.5)
Data missing 118 (5.7) 79 (6.1) 29 (6.7) 5 (2.8) 5 (3.1)
Smoking history
Never 663 (32.2) 434 (33.7) 155 (35.8) 35 (19.8) 39 (23.9)
Ever 1,381 (67.0) 846 (65.7) 272 (62.8) 139 (78.5) 124 (76.1)
Data missing 17 (0.8) 8 (0.6) 6 (1.4) 3 (1.7) 0
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and 10 or more (21.1%). Overall, the prevalence of one AK or
more was 49.0% (95% confidence interval (CI): 45.8–52.2%)
for men and 28.1% (25.5–30.7%) for women (Supplementary
Table S1 online). AK prevalence increased with age in both
men and women, but there was a small dip in the age category
of 80–84 years compared with younger age groups in men and
women (Supplementary Table S1 online and Figure 1).
Extrapolation to the Netherlands showed that 1,408,641 of
the 5,985,164 Dutch citizens aged 50 years or older were
affected by AK in 2011, of which 817,823 (58%) were men
and 596,487 (42%) were women. This corresponds to an AK
prevalence of 23.5% (95% CI: 21.7–25.3%) in the Dutch
population aged 50 years or older; 28.8% (25.9–31.7%) for
men; and 19.0% (16.7–21.2%) for women.
Location of AKs
The face was the location most commonly affected by 1–3
(42.5%) and 4–9 (33.4%) AK, whereas X10 (36.2%) AKs
were more frequently located on the scalp (Supplementary
Table S2 online). Stratification by sex showed that extensive
actinic damage (X10 AKs) was most often found on the scalp
(47.5%) in bald men, whereas this was 0.0% in women
(Supplementary Table S2 online).
Risk factors of AKs
In Supplementary Table S3 online, the results of the univariate
multinomial logistic regression were shown. Medium baldness
was associated with 4–9 (odds ratio (OR) 1.8 (95% CI: 1.2–2.8))
and X10 AKs (OR 2.1 (95% CI: 1.3–3.4)), whereas severe
Table 1. (Continued )
Total study population No AK (%) 1–3 AKs (%) 4–9 AKs (%) X10 AKs (%)
Characteristic (n¼ 2,061) (n¼ 1,288) (n¼433) (n¼ 177) (n¼163)
Education level3
Low 374 (18.1) 235 (18.2) 78 (18.0) 31 (17.5) 30 (18.4)
Medium 1,215 (59.0) 751 (58.3) 271 (62.6) 106 (59.9) 87 (53.4)
High 444 (21.5) 285 (22.1) 78 (18.0) 39 (22.0) 42 (25.8)
Data missing 28 (1.4) 17 (1.3) 6 (1.4) 1 (0.06) 4 (2.5)
Abbreviations: AK, actinic keratosis; FBSE, full-body skin examination; n, number; RS, Rotterdam Study.
1Based on the Norwood–Hamilton scale for men and Ludwig scale for women.
2Wearing sunglasses and/or a rimmed hat in the sunshine.
3Low (primary education and primary education with a higher not completed education), medium (lower-level secondary education, lower-level vocational
education intermediate-level vocational education), and high (general secondary education, higher-level vocational education and university).
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Figure 1. Prevalence of actinic keratoses (AKs) among 2,061 participants of the Rotterdam Study (RS), stratified by sex. CI, confidence interval.
SC Flohil et al.
Prevalence and Risk Factors of AK
www.jidonline.org 1973
Table 2. Multivariate multinomial logistic regression: risk factors associated with AKs among 2,061 participants of
the RS
Characteristic
1–3 AKs adjusted
OR (95% CI)
4–9 AKs adjusted
OR (95% CI)
X10 AKs adjusted
OR (95% CI)
P-value1 (based on ordinal
logistic regression)
Sex
Women 1.0 (ref) 1.0 (ref) 1.0 (ref)
Men 2.2 (1.6 -2.9) 2.5 (1.5–3.9) 3.2 (1.8–5.6) Po0.001
Age at clinical examination
o70 1.0 (ref) 1.0 (ref) 1.0 (ref)
70–79.99 1.6 (1.2–2.1) 2.0 (1.4–3.0) 3.7 (2.3–6.0) Po0.001
X80 1.7 (1.1–2.7) 2.7 (1.5–5.0) 6.5 (3.4–12.4) Po0.001
Pigmentation status (based on eye, hair, and skin color)
Dark 1.0 (ref) 1.0 (ref) 1.0 (ref)
Medium 1.7 (1.1–2.8) 1.5 (0.8–3.0) 1.3 (0.6–2.7) P¼ 0.05
Light 2.3 (1.3–3.8) 1.9 (0.9–4.1) 2.5 (1.1–5.7) Po0.001
Glogau scale
1 and 2 1.0 (ref) 1.0 (ref) 1.0 (ref)
3 3.7 (1.9–7.0) 4.1 (1.4–11.7) 8.0 (1.9–34.8) Po0.001
4 5.5 (2.6–11.5) 4.9 (1.5–16.2) 6.0 (1.2–29.4) Po0.001
Nevi
o25 1.0 (ref) 1.0 (ref) 1.0 (ref)
25–50 1.4 (1.0–1.9) 1.3 (0.8–2.0) 1.0 (0.6–1.8) P¼ 0.15
50 or more 1.3 (0.7–2.2) 1.6 (0.8–3.4) 1.3 (0.5–3.2) P¼ 0.29
Baldness2
No/almost no baldness 1.0 (ref) 1.0 (ref) 1.0 (ref)
Mild baldness 0.8 (0.6–1.1) 1.1 (0.7–1.8) 1.2 (0.7–2.0) P¼ 0.79
Severe baldness 1.2 (0.8–1.8) 4.1 (2.5–6.8) 6.3 (3.6–11.0) Po0.001
Tendency to develop sunburn
Low 1.0 (ref) 1.0 (ref) 1.0 (ref)
High 1.4 (1.0–1.8) 2.0 (1.3–2.9) 3.3 (2.2–5.0) Po0.001
Data missing
Outdoor work history X25 years
No 1.0 (ref) 1.0 (ref) 1.0 (ref)
Yes 0.9 (0.5–1.7) 1.6 (0.7–3.5) 0.6 (0.3–1.5) P¼ 0.60
Data missing
History of living in a sunny country of 41 year
No 1.0 (ref) 1.0 (ref) 1.0 (ref)
Yes 0.8 (0.5–1.2) 0.3 (0.1–0.7) 0.7 (0.4–1.3) P¼ 0.01
Data missing
Sun-protective behavior3
Never/almost never 1.0 (ref) 1.0 (ref) 1.0 (ref)
Often/not always 1.3 (0.9–1.7) 1.9 (1.3–2.0) 2.5 (1.5–4.1) Po0.001
Always 1.2 (0.9–1.6) 1.2 (0.8–2.0) 2.0 (1.2–3.4) P¼ 0.02
Data missing
Smoking history
Never 1.0 (ref) 1.0 (ref) 1.0 (ref)
Ever 0.7 (0.5–0.9) 1.3 (0.8–2.0) 0.9 (0.6–1.4) P¼ 0.4
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baldness was associated with all three outcome groups
in a linear manner up to an OR of 13.9 (9.3–20.7) for X10
AKs compared with no or minimal hairloss. Nevi, outdoor
work history, and educational level were not significantly
associated with AK, whereas ever smoking was associated
with 4–9 andX10 AKs (OR 2.0 (95% CI: 1.4–3.0) and OR 1.6
(95% CI: 1.1–2.4), respectively). All significant variables in the
univariate, except smoking, remained significantly associated
with AK in the multivariate multinomial model (Table 2).
Severe baldness remained the strongest risk factor for X10
AKs (adjusted OR 6.3 (95% CI: 3.6–1.0); P-value for trend
o0.001). After stratification by sex (data not shown), severe
baldness remained significantly associated with X10 AKs in
men (adjusted OR 7.0 (3.8–13.1)), but not in women (no OR
could be calculated, as only 8 women had severe baldness).
Male sex, the age of 70 years or older, Glogau 3 and 4, and
the tendency to develop sunburn remained significantly
associated with all three outcome groups. Light pigmentation
status was associated with 1–3 (OR 2.3 (95% CI: 1.3–3.8)) and
X10 AKs (OR 2.5 (95% CI: 1.1–5.7)), but not with 4–9 AKs.
Use of sun-protective measurement was associated with X10
AKs (adjusted OR 2.0 (95% CI: 1.2–3.4)).
The multivariate binary logistic regression was in line
with the results of the multinomial model (Supplementary
Table S4 online).
Skin cancer history and detection during FBSE
In total, 238 (11.5%) participants had a history of basal cell
carcinoma (BCC), 51 (2.5%) had a history of SCC, and 20
(0.5%) had a history of melanoma. The risk of a history of one
of these cutaneous malignancies increased across the AK
severity strata (i.e., from none to X10 AKs). For BCC, SCC,
and melanoma, these risks increased, respectively, from 7.2 to
26.5%, 1.2 to 13.6%, and 0.7 to 1.9% (Supplementary
Figure S1 online). Although these risks increased gradually
for BCC and melanoma, a sharper increase was seen for SCC.
Participants with X10 AKs (13.6%) had a three-fold higher
risk for having a SCC history compared with participants with
4–9 AKs (4.0%). Of the 2,061 participants who received a
FBSE during our study period, it was histologically confirmed
that 59 (2.9%) had a BCC, 11 (0.5%) had a SCC, and 9 (0.4%)
had melanoma (including 5 invasive and 4 in situ). Overall,
the detection rate of these cutaneous malignancies in our
study population was 4.0% (82 out of 2,061 participants).
DISCUSSION
In this Dutch population-based study, including more than
2,000 individuals with a mean age of 72 years who were
examined by trained physicians, almost 38% had one or more
AK and 8% had 10 or more (age- and sex-adjusted 23% and
5%, respectively). This AK prevalence is the highest in
individuals aged 50 years or older when compared with
previous European population-based studies and comparable
to or less than studies from the USA and Australia (Harvey
et al., 1996a; Naldi et al., 2006).
In Europe, the South Wales Skin Cancer Study observed an
AK prevalence of 23% (95% CI: 19.5–26.5), unadjusted for
age and sex, among 1,034 persons aged 60 years or older. The
lower prevalence may be explained by the fact that skin
examinations were limited to the head and neck, lower arms
(until shoulders), lower legs, and feet, and were performed by
research registrars in dermatology. Recently, in the PRAKTIS
study, a representative sample of 12,483 individuals of the
Italian population aged 445 years were selected by a
stratified random sampling design in which 1.4% of the
individuals were affected by AK (Naldi et al., 2006). Again,
skin examinations were performed by ‘‘interviewers’’ and
limited to the face and upper extremities (Naldi et al.,
2006). In addition, the distribution of phenotypic
characteristics of the Dutch (i.e., light skin, hair, and eyes)
increase the risk for AK development when compared with the
distribution in the Italian population with slightly darker skin,
hair, and eyes. German studies using claims data estimated AK
prevalences ranging from 2 to 31%, but these data were not
population based and included dermatology patients (Breitbart
et al., 2012; Guther et al., 2012), patients without history of
skin cancer who were invited to undergo skin examination
when visiting their practice-based physician, or healthy
workers who could undergo a voluntary FBSE at their
workplace (Augustin et al., 2011). Between 1971 and 1975,
a population-based study across the USA (He et al., 2011), in
which 101 dermatologists performed FBSE in more than 8,000
white participants aged between 25 and 74 years, observed a
crude AK prevalence of around 17% (He et al., 2011). More
Table 2. (Continued )
Characteristic
1–3 AKs adjusted
OR (95% CI)
4–9 AKs adjusted
OR (95% CI)
X10 AKs adjusted
OR (95% CI)
P-value1 (based on ordinal
logistic regression)
Education level4
Low 1.0 (ref) 1.0 (ref) 1.0 (ref)
Medium 1.1 (0.8–1.4) 1,1 (0.7–1.8) 0.9 (0.5–1.4) P¼ 0.84
High 0.8 (0.5–1.1) 1.0 (0.6–1.7) 0.9 (0.5–1.6) P¼ 0.27
Abbreviations: AKs, actinic keratosis; FBSE, full-body skin examination; OR, odds ratio.
1P-value based on multivariate ordinal logistic regression.
2Based on the Norwood–Hamilton scale for men and Ludwig scale for women.
3Wearing sunglasses and/or a rimmed hat in the sunshine.
4Low (primary education and primary education with a higher not completed education), medium (lower-level secondary education, lower-level vocational
education intermediate-level vocational education), and high (general secondary education, higher-level vocational education, and university).
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recently, the crude prevalence for AK in the United States was
estimated to be 45% in men aged 65 years or older and 35%
in women (Almeida and Stratakis, 2010). Two Australian
studies from the eighties who screened 2,095 and 1,040
individuals randomly selected from sample state electoral
roll demonstrated that 40–60% of the participants had at least
one AK (Marks et al., 1986; Green et al., 1988).
Risk factors and implications
Multiple risk factors were found to be associated with AK
development, confirming findings of previous studies assessing
AK and SCC risk factors (Marks et al., 1988a; Green and
Battistutta, 1990). In men, baldness was found to be the
strongest risk factor for the presence of AK and severe actinic
skin damage, probably because it continuously exposes the
scalp in a horizontal plane to UV radiation, resulting in high
cumulative UV doses. In clinical practice, these patients with
large cutaneous fields affected by AK on the scalp are
numerous and difficult to manage.
Although it remains controversial whether or not to actively
treat AK (as not all will progress to SCC), individuals with
multiple lesions (in this study defined as X10) are most likely
to benefit from treatment and require a closer follow-up over
time to prevent or detect the early development of SCC. Even
this conservative approach is a health-care challenge, because
it involves 5% of the Dutch 50-plus citizens (B300,000
individuals), and this proportion is likely to increase over
time. This is confirmed by a quick review of the claims
data demonstrating that dermatologists reported twice
as many AK-related visits and treatment between 2007 and
2011 (from 42,115 to 76,395), emphasizing the strain cuta-
neous (pre-)malignancies put on the health-care system
(Nan et al., 2011).
Strengths and limitations
The fact that FBSE was performed by a few trained physicians
in more than 2,000 participants from a population-based study
makes the Dutch point prevalence highly accurate. In general,
AK have a typical presentation and are therefore clinically
diagnosed by dermatologists and general practitioners. How-
ever, AK can resemble keratinocyte carcinoma (including
BCC and SCC), possibly leading to misclassification and
an underestimation or overestimation of AK in this study
(Criscione et al., 2009). Nevertheless, this possible non-
differential misclassification is considered small, as trained
physicians performed FBSE and previous studies observed a
positive predictive value for AK diagnosis ranging from 74 to
94% (Ponsford et al., 1983; Venna et al., 2005). In this study,
AK prevalence was determined cross-sectionally, and it was
unknown whether participants were previously treated for AK,
which also could have resulted in an underestimation of the
Dutch AK prevalence. Unfortunately, the design of the study
does not allow a longitudinal follow-up of individual AK to
study its natural course. The individual number of AK lesions
within a participant was not counted; instead, AK presence
was divided into three categories (i.e., 1–3, 4–9,X10).
Although categorical data are less precise than continuous
data, previous studies showed that the inter-observer variation
between dermatologists was large when counting the indivi-
dual number of AK lesions within a participant, and using
categorized data greatly reduced this variation (Weinstock
et al., 2001). The population of the RS is 45 years and
older and almost exclusively Caucasian, possibly limiting
the generalizibility of the findings. However, none of the
participants aged below 55 years (n¼50) had AK, and AKs are
rare in individuals with darker skin, suggesting that the extent
of this limitation is rather small. At the time of FBSE, only feet
and areas covered by underwear were not examined, because
of practical and psychological reasons. It is unlikely that
this restriction resulted in an underestimation of the AK
prevalence, because these areas are not chronically UV
exposed.
Conclusions
Cutaneous (pre)maligancies are an enormous burden for
health-care providers. Preventive measures including
First cohort:
(RS-I)
Second cohort:
(RS-II)
Third cohort:
(RS-III)
...
2012 ...1990 
1990 
RS – I –1
N = 7,983
RS – I – 3 RS – I – 4RS – I – 2
N = 6,315 N = 4,797 N = 3,550
RS – II – 2RS – II – 1
N = 3,011 N = 2,389
RS – III – 1
N = 3,932
RS – I – 5
N = 2,140
RS – II – 3
N = 1,542
RS – III – 2
N = ...
2012
N = 2,061
Participants
with FBSE
Figure 2. Flowchart of the Rotterdam Study (RS). FBSE, full-body skin examination.
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promoting sun-protective behavior and raising awareness on
cutaneous keratinocyte carcinoma and persistent AK should
focus in particular on elderly, bald men and those with
photodamaged facial skin to reduce the number of SCC.
MATERIALS AND METHODS
Study population
The RS is an ongoing prospective population-based cohort study
that follows inhabitants of the Ommoord district of Rotterdam,
the Netherlands since 1990. The study design and objectives of the
RS have been described elsewhere (Hofman et al., 2011).
In January 1990, the first cohort (RS-I) of 7,983 participants (78% of
invitees) aged 55 years or older was established (Figure 2). In 2000,
a second cohort (RS-II) was added to the RS, including 3,011
participants (67% of invitees) who had turned 55 years of age or
had moved into the study district. The third cohort (RS-III)
was established in 2006, in which 3,932 participants (65% of
invitees) aged 45–54 years were added to the cohort. Participants of
the present study were all above 50 years of age. The RS is approved
by the Medical Ethics Committee of the Erasmus MC University
Medical Center and The Netherlands Ministry of Health, Welfare and
Sports. Our study was conducted in accordance with the Helsinki
guidelines. All patients participating in the RS gave written informed
consent.
Dermatology in the RS
In August 2010, dermatology was introduced in the RS (Figure 2).
Since then, FBSE (with the exception of the feet and the skin covered
by socks and underwear, respectively) are being conducted by four
trained physicians focussing on the most common skin diseases such
as skin (pre-)malignancies, atopic dermatitis, hand eczema, psoriasis,
and varicose veins.
Actinic keratoses
An AK was diagnosed clinically and was defined as a rough
(keratotic) lesion with adherent scaling and erythema, not fitting
another diagnosis (Weinstock et al., 2001). As AK lesions are often
confluent and located on sun-damaged skin, it is difficult to count the
total number of individual lesions within a participant (Weinstock
et al., 2001).
We counted the overall number of AK per participant and
subdivided this into the number of AK per localization using the
same categories: no presence of AK, 1–3, 4–9, or X10 AKs. The
subdivision per anatomical localization consisted of the most impor-
tant sun-exposed areas including scalp, face (excluding ears), ears,
neck, back of hands, forearms, chest, or other localizations.
Risk factors
Sex and age (in years) at date of skin examination were registered.
Educational level (classified into three categories: low (primary
education and primary education with a higher not completed
education), medium (lower-level secondary education, lower-level
vocational education intermediate-level vocational education), and
high (general secondary education, higher-level vocational educa-
tion, and university)), smoking (never versus ever), hair color at young
age (red, fair/blond, dark blond/brown, and black), and four questions
assessing UV exposure were available from interview data. The
questions on UV exposure included the tendency for sunburns,
history of more than 25 years of outdoor work, having lived more
than 1 year in a sunny country, and sun-protective behavior (i.e.,
wearing sunglasses and/or a rimmed hat in the sunshine). The first
three UV items had binary responses, and the latter was categorized
into never/almost never, often/not always, and always. Eye color
(blue, intermediate, brown) was available from and scored by the
ophthalmology department within the RS.
During FBSE, the following potential phenotypic risk factors for AK
were scored: skin color (very white (3.4%), white (79.1%), white to
olive (14.5%), light brown (1.7%), brown (1.1%), dark brown/ black
(0.2%)), Glogau score (type 1 ‘‘no wrinkles’’, type 2 ‘‘wrinkles in
motion’’, type 3 ‘‘wrinkles at rest’’, and type 4 ‘‘only wrinkles’’)
(Glogau, 1996), number of nevi (o25, 25–50, 50–100, 4100), and
baldness of the scalp based on the Norwood–Hamilton (Norwood,
1975; Taylor et al., 2004) scale for men and the Ludwig scale
(Ludwig, 1977) for women. In the analyses, baldness of the scalp was
divided into none or minimal (Norwood–Hamilton score A, B, C, I, J,
and Ludwig scale score 1), mild (Norwood–Hamilton score D,E,F,K,
and Ludwig scale score 2), and extensive baldness (Norwood–
Hamilton score G, H, L, and Ludwig scale score 3).
Because of significant correlation (phi-test for correlation,
Po0.001) between the phenotypic characteristics, hair color at young
age, eye color, and skin color, these three variables were combined
into one variable ‘‘pigmentation status’’ and classified by light,
medium, or dark pigmentation status.
Skin cancer history
All RS participants were linked to PALGA, the Dutch nationwide
network and registry of histo- and cytopathology in the Netherlands,
which contains excerpts of all pathology reports with nationwide
coverage from 1991 onward (Casparie et al., 2007). A linkage
between PALGA and our study population was made until
23 September 2011, and has been described before (Flohil et al.,
2011). An excerpt encloses encrypted patient data, a summary of the
pathology report, and a diagnosis line based upon standard pathology
terminology similar to the Systematized Nomenclamenture of
Medicine issues by the College of American Pathologists.
Individuals in the database have an encrypted patient identification
code that enables linkage with all available pathology data within
PALGA. The search in PALGA was based on codes corresponding to
all types of BCC (Flohil et al., 2011). Participants were counted only
once per cutaneous malignancy (Figure 2).
Statistical analyses
The prevalence of AK within the 2,061 studied participants of the RS
was standardized by age (5-year bands) and sex, and 95% CIs for
proportion were calculated. The sex- and age-specific prevalences
were multiplied by the sex- and age-specific population size in the
Netherlands (5-year bands). Population size was obtained from
Statistics Netherlands and estimated on the first of January 2011
(Wisgerhof et al., 2010). Extrapolated AK prevalence was calculated
for the Dutch population aged 50 years or older.
To investigate risk factors associated with the development
of AK, univariate and multivariate multinomial logistic regression
analyses were performed and OR with 95% CI were calculated for
each of the three outcome groups: 1–3, 4–9, and X10 AKs.
In addition, considering the ordinal structure of the latter outcome
groups, an ordinal logistic regression was used to provide a
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cumulative OR. A significant cumulative OR corresponds to a
statistically significant trend of increase in risk across the AK strata
(Qureshi et al., 2012; Wei-Passanese et al., 2012). A corresponding P-
value for trend (based on the ordinal logistic regression) was
calculated (Table 2). However, not all variables met the proportional
odds assumption for this test and fitted therefore better in the
multinomial logistic regression model.
To compare participants with extensive actinic damage (X10 AKs)
with those with no or less actinic damage (0–9 AKs), univariate
and multivariate binary logistic regression analyses were used
to calculate (adjusted) OR with 95% CI. All variables included
in the univariate analyses were included in the multivariate
analyses as possible confounders for AK risk. No significant interac-
tion terms were observed. All statistical analyses were performed
using SPSS for Windows version 17.0 (SPSS, Chicago, IL). P-values
were two-sided and considered statistically significant if P-value
was o0.05.
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